New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma

Area of Science:

• Medicinal Chemistry
• Oncology
• Drug Discovery

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with poor therapeutic outcomes.
• Limited treatment options exist due to late diagnosis, aggressive nature, and drug resistance.

Purpose of the Study:

• To design, synthesize, and evaluate novel topsentin derivatives with a 1,2,4-oxadiazole core for anticancer activity.
• To identify potent inhibitors of pancreatic cancer cell proliferation, migration, and clonogenicity.

Main Methods:

• Synthesis of a new series of 1,2,4-oxadiazole derivatives.
• Screening of antiproliferative activity against PDAC cell lines (SUIT-2, Patu-T, PANC-1).
• Assessment of cell migration and clonogenic potential.

Main Results:

• Several synthesized compounds exhibited potent antiproliferative effects on PDAC cells, especially SUIT-2 and Patu-T.
• These derivatives significantly inhibited cancer cell migration and reduced colony formation.
• IC50 values were in the micromolar range, indicating significant potency.

Conclusions:

• The marine-inspired 1,2,4-oxadiazole derivatives effectively target key PDAC hallmarks.
• These compounds demonstrate potential for overcoming drug resistance and metastatic progression in pancreatic cancer.
• Further development is warranted for these promising anticancer candidates.